Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium inhalation powder in COPD (Phase II, China)
CTR20131544Phase 2Active
- Sponsor
- Shanghai Huashi Pharmaceutical
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Shanghai Huashi Pharmaceutical. Started Apr 2014; status: active.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20131544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131544.